Purple Biotech Ltd. — Cyborg Score 4/10

Strategic Profile

Capping technology confines immune activation to the tumor microenvironment, significantly expanding the therapeutic window compared to conventional T-cell engagers. The platform consists of capped tri-specific antibodies with IM1240 as the lead 5T4-targeting candidate and IM1305 as the TROP2-targeting development candidate.

Cyborg Score Rationale

The company regained Nasdaq compliance in March 2026 after previously facing minimum bid price deficiencies. While the lead program shows clinical promise with emerging efficacy data, the company faces typical clinical-stage biotech execution risk with no approved products and capital requirements ahead.

Top Insights

• Lead program CAPTN-3 represents a novel masked tri-specific antibody approach designed to improve tolerability versus conventional T-cell engagers
• (May 2026) IM1240 demonstrated anti-tumor activity across treatment-resistant patient-derived samples, supporting clinical advancement
• Company regained Nasdaq listing compliance in March 2026 after addressing minimum bid price violations in 2025
• Dual pipeline approach with CAPTN-3 antibodies (IM1240, IM1305) plus legacy small molecule programs (NT219, CM24)

Named Competitors

• Keytruda — PD-1 checkpoint inhibitor for multiple cancer indications
• Tecentriq — PD-L1 checkpoint inhibitor for oncology
• Yescarta — CAR-T cell therapy for hematologic malignancies

Recent Developments

• (March 2026) Regained Nasdaq compliance after maintaining minimum $1.00 ADS bid price for 10 consecutive business days
• (March 2026) CEO Gil Efron announced stepping down in August 2026 for health considerations while continuing corporate development
• (May 2026) Announced IM1240 preclinical data showing anti-tumor activity with NKG2A arm enhancing activity in NSCLC samples
• (Q1 2026) Reported preclinical progress on IM1240 tri-specific antibody across multiple tumor models

Open the full interactive Purple Biotech Ltd. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.